Let’s build the future of Duke innovation together
Duke Capital Partners leverages the power of the Duke network to support the university’s entrepreneurial ecosystem. We seek the most audacious Duke founders, investors, and students to build the boldest startups solving the world’s most pressing challenges.
We capitalize on the strength of the global Duke network to provide access to capital, mentorship, and support for Duke-connected portfolio companies.
Our Associate program in venture capital is unique among universities, and students complete our two-year program with live investment experience that is difficult to obtain anywhere else in graduate school.
For investors with a Duke connection, we facilitate investment opportunities as well as full-circle engagement with the University.
About Duke Capital Partners
Duke Capital Partners is committed to supporting the Duke entrepreneurial and innovation ecosystem through education and mentorship, access to capital, and connections to a global base of Duke alumni talent.
Trailblazing uncharted territory isn’t easy, but that’s what leaders do. As one of the largest and oldest university investment entities of its kind, Duke Capital Partners consistently places among the top five in North America. We deploy more capital than any other university investment network, and provide full lifecycle support for our founders and portfolio companies.
Our portfolio companies dream big. They’re working to solve some of the world’s most pressing challenges with outrageous ambition. The 44 companies we’ve invested in have a combined enterprise value exceeding $4 billion, have created more than 2,500 jobs, and are pushing against the outer realms of possibility. Audacious ideas breed next-generation innovation.
Our Associate program places education at the core of our operations. Since 2015, more than 90 Duke graduate students have completed our program, learning investment sourcing, screening, and diligence.
Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development
Preclinical research agreement brings together Duke start-up Xilis' MicroOrganoSphere™ platform with MD Anderson's expertise in cancer research and therapeutic development.
Read More about Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development
restor3d Celebrates Major Milestones in Personalized Orthopaedics
restor3d celebrates first implantation of device featuring their TIDAL Technology™, and more
Read More about restor3d Celebrates Major Milestones in Personalized Orthopaedics
restor3d’s Cambre Kelly named Forbes 30 under 30
Cambre cofounded restor3d while researching her doctoral thesis in biomedical engineering at Duke University.
Read More about restor3d’s Cambre Kelly named Forbes 30 under 30